Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-Xa Concentrations With Continuous Intravenous Infusion and Subcutaneous Administration of Enoxaparin After Coronary Artery Bypass Grafting: Randomized Clinical Trial

NCT02474212 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.

NCT NCT02474212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02474212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-Xa Concentrations With Continuous Intravenous Infusion and Subcutaneous Administration of Enoxaparin After Coronary Artery Bypass Grafting: Randomized Clinical Trial
Lead sponsor
Tampere University Hospital
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2016
Completion date
March 31, 2023
Enrollment
85 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary embolism, thromboprophylaxis, venous thromboembolism